Page 128 - 南京医科大学学报自然科学版
P. 128
第42卷第7期
·1024 · 南 京 医 科 大 学 学 报 2022年7月
(6):774-777 scription of DNA ⁃ based noninvasive prenatal screening
[3] JOSEPH L,FARMER C,CHLEBOWSKI C,et al. Charac⁃ [J]. N Engl J Med,2015,372(17):1675-1677
terization of autism spectrum disorder and neurodevelop⁃ [17] ZHANG H,GAO Y,JIANG F,et al. Non⁃invasive prena⁃
mental profiles in youth with XYY syndrome[J]. J Neuro⁃ tal testing for trisomies 21,18 and 13:clinical experience
dev Disord,2018,10(1):30 from 146,958 pregnancies[J]. Ultrasound Obstet Gyne⁃
[4] 丁旭锋,马年娣,史卿菁,等. 性染色体数目异常疾病在 col,2015,45(5):530-538
新生儿期进行筛查的意义[J]. 中国优生与遗传杂志, [18] GREGG A R,SKOTKO B G,BENKENDORF J L,et al.
2019,27(9):1149-1152 Noninvasive prenatal screening for fetal aneuploidy,2016
[5] SAMANGO⁃SPROUSE C A,PORTER G F,LASUTSCH⁃ update:a position statement of the American college of
INKOW P C,et al. Impact of early diagnosis and noninva⁃ medical genetics and genomics[J]. Obstet Gynecol Surv,
sive prenatal testing(NIPT):knowledge,attitudes,and 2017,72(1):6-8
experiences of parents of children with sex chromosome [19] YIN A H,PENG C F,ZHAO X,et al. Noninvasive detec⁃
aneuploidies(SCAs)[J]. Prenat Diagn,2020,40(4): tion of fetal subchromosomal abnormalities by semicon⁃
470-480 ductor sequencing of maternal plasma DNA[J]. Proc Natl
[6] 殷旭阳,陈 芳,王 威. 孕妇血浆游离核酸高通量测 Acad Sci USA,2015,112(47):14670-14675
序检测胎儿遗传异常[J]. 中国产前诊断杂志(电子 [20] 黄晓莉,孙丽洲. 218例侧脑室增宽胎儿的染色体检测
版),2016,8(2):44-51 结果和妊娠结局分析[J]. 南京医科大学学报(自然科
[7] 王一鹏,王 威,李珊珊,等. 无创产前筛查在胎儿性染 学版),2021,41(4):593-599,633
色体非整倍体产前筛查及诊断中的应用[J]. 中国医 [21] DUGOFF L,MENNUTI M T,MCDONALD⁃MCGINN D
刊,2020,55(6):672-674 M. The benefits and limitations of cell⁃free DNA screen⁃
[8] 姚润斯,马 容,揭深秋,等. 无创产前基因检测在胎儿 ing for 22q11.2 deletion syndrome[J]. Prenat Diag,
性染色体疾病筛查中的应用[J]. 中国产前诊断杂志 2017,37(1):53-60
(电子版),2020,12(1):14-19 [22] 李雅红,林 颖,孙 云,等. 性染色体异常无创产前筛
[9] 沈福民. 流行病学原理与方法[M]. 上海:上海医科大 查回顾性研究[J]. 检验医学与临床,2016,13(4):505-
学出版社,2001:98-107 507
[10] 郑芸芸,万陕宁,宋婷婷,等. 8594 例孕妇无创 DNA 产 [23] MILLER D T,ADAM M P,ARADHYA S,et al. Consen⁃
前检测在胎儿染色体非整倍体疾病筛查中的临床应用 sus statement:chromosomal microarray is a first⁃tier clini⁃
[J]. 实用妇产科杂志,2019,35(1):68-71 cal diagnostic test for individuals with developmental dis⁃
[11] ZHANG B,LU B Y,YU B,et al. Noninvasive prenatal abilities or congenital anomalies[J]. Am J Hum Genet,
screening for fetal common sex chromosome aneuploidies 2010,86(5):749-764
from maternal blood[J]. J Int Med Res,2017,45(2): [24] MARDY A,WAPNER R J. Confined placental mosaicism
621-630 and its impact on confirmation of NIPT results[J]. Am J
[12] PETERSEN A K,CHEUNG S W,SMITH J L,et al. Posi⁃ Med Genet Part C Semin Med Genet,2016,172(2):118-
tive predictive value estimates for cell ⁃ free noninvasive 122
prenatal screening from data of a large referral genetic di⁃ [25] BENN P,BORRELL A,CHIU R W K,et al. Position
agnostic laboratory[J]. Am J Obstet Gynecol,2017,217 statement from the chromosome abnormality screening
(6):691.e1-691.e6 committee on behalf of the board of the international soci⁃
[13] 陆欣然. 无创产前检测技术在性染色体非整倍体疾病 ety for prenatal diagnosis[J]. Prenat Diagn,2015,35(8):
检测中的应用:45773例孕妇的回顾性研究[D]. 合肥: 725-734
安徽医科大学,2021 [26] LEVY B,WAPNER R. Prenatal diagnosis by chromosom⁃
[14] LIANG D,CRAM D S,TAN H,et al. Clinical utility of al microarray analysis[J]. Fertil Steril,2018,109(2):
noninvasive prenatal screening for expanded chromosome 201-212
disease syndromes[J]. Genet Med,2019,21(9):1998- [27] WOU K,CHUNG W K,WAPNER R J. Laboratory consid⁃
2006 erations for prenatal genetic testing[J]. Semin Perinatol,
[15] 马燕琼. 无创产前检测技术在宁夏地区胎儿性染色体 2018,42(5):307-313
异常检测中的应用价值[D]. 银川:宁夏医科大学, [28] CHINNERY P F,JOHNSON M A,WARDELL T M,et al.
2018 The epidemiology of pathogenic mitochondrial DNA muta⁃
[16] CHEUNG S W,PATEL A,LEUNG T Y. Accurate de⁃ (下转第1035页)